Literature DB >> 21393251

Tumor necrosis factor receptor-associated factor (TRAF) 2 controls homeostasis of the colon to prevent spontaneous development of murine inflammatory bowel disease.

Jiang-Hu Piao1, Mizuho Hasegawa, Beate Heissig, Koichi Hattori, Kazuyoshi Takeda, Yoichiro Iwakura, Ko Okumura, Naohiro Inohara, Hiroyasu Nakano.   

Abstract

Fine-tuning of host cell responses to commensal bacteria plays a crucial role in maintaining homeostasis of the gut. Here, we show that tumor necrosis factor receptor-associated factor (Traf)2(-/-) mice spontaneously developed severe colitis and succumbed within 3 weeks after birth. Histological analysis revealed that apoptosis of colonic epithelial cells was enhanced, and B cells diffusely infiltrated into the submucosal layer of the colon of Traf2(-/-) mice. Expression of proinflammatory cytokines, including Tnfa, Il17a, and Ifng, was up-regulated, whereas expression of antimicrobial peptides was down-regulated in the colon of Traf2(-/-) mice. Moreover, a number of IL-17-producing helper T cells were increased in the colonic lamina propria of Traf2(-/-) mice. These cellular alterations resulted in drastic changes in the colonic microbiota of Traf2(-/-) mice compared with Traf2(+/+) mice. Treatment of Traf2(-/-) mice with antibiotics ameliorated colitis along with down-regulation of proinflammatory cytokines and prolonged survival, suggesting that the altered colonic microbiota might contribute to exacerbation of colitis. Finally, deletion of Tnfr1, but not Il17a, dramatically ameliorated colitis in Traf2(-/-) mice by preventing apoptosis of colonic epithelial cells, down-regulation of proinflammatory cytokines, and restoration of wild-type commensal bacteria. Together, TRAF2 plays a crucial role in controlling homeostasis of the colon.
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393251      PMCID: PMC3093863          DOI: 10.1074/jbc.M111.221853

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA.

Authors:  G Muyzer; E C de Waal; A G Uitterlinden
Journal:  Appl Environ Microbiol       Date:  1993-03       Impact factor: 4.792

2.  Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.

Authors:  H Nakano; S Sakon; H Koseki; T Takemori; K Tada; M Matsumoto; E Munechika; T Sakai; T Shirasawa; H Akiba; T Kobata; S M Santee; C F Ware; P D Rennert; M Taniguchi; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

3.  Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration.

Authors:  Y P De Jong; M Comiskey; S L Kalled; E Mizoguchi; R A Flavell; A K Bhan; C Terhorst
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

Review 4.  The immunology of mucosal models of inflammation.

Authors:  Warren Strober; Ivan J Fuss; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

5.  TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.

Authors:  Adrian P Grech; Michelle Amesbury; Tyani Chan; Sandra Gardam; Antony Basten; Robert Brink
Journal:  Immunity       Date:  2004-11       Impact factor: 31.745

Review 6.  Homeostasis and inflammation in the intestine.

Authors:  Wendy S Garrett; Jeffrey I Gordon; Laurie H Glimcher
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

7.  Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.

Authors:  W C Yeh; A Shahinian; D Speiser; J Kraunus; F Billia; A Wakeham; J L de la Pompa; D Ferrick; B Hum; N Iscove; P Ohashi; M Rothe; D V Goeddel; T W Mak
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

8.  TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses.

Authors:  L T Nguyen; G S Duncan; C Mirtsos; M Ng; D E Speiser; A Shahinian; M W Marino; T W Mak; P S Ohashi; W C Yeh
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

9.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Authors:  K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

10.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.

Authors:  Susumu Nakae; Yutaka Komiyama; Aya Nambu; Katsuko Sudo; Michiko Iwase; Ikuo Homma; Kenji Sekikawa; Masahide Asano; Yoichiro Iwakura
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

View more
  18 in total

1.  Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy.

Authors:  Kai-Chun Yang; Xiucui Ma; Haiyan Liu; John Murphy; Philip M Barger; Douglas L Mann; Abhinav Diwan
Journal:  Circ Heart Fail       Date:  2014-10-22       Impact factor: 8.790

2.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

3.  TRAF2 is a biologically important necroptosis suppressor.

Authors:  S L Petersen; T T Chen; D A Lawrence; S A Marsters; F Gonzalvez; A Ashkenazi
Journal:  Cell Death Differ       Date:  2015-04-17       Impact factor: 15.828

Review 4.  Targeting signaling factors for degradation, an emerging mechanism for TRAF functions.

Authors:  Xiao-Dong Yang; Shao-Cong Sun
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

Review 5.  Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.

Authors:  Dylan K McDaniel; Kristin Eden; Veronica M Ringel; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

6.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

7.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13

8.  Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages.

Authors:  Jin Jin; Yichuan Xiao; Hongbo Hu; Qiang Zou; Yanchuan Li; Yanpan Gao; Wei Ge; Xuhong Cheng; Shao-Cong Sun
Journal:  Nat Commun       Date:  2015-01-07       Impact factor: 14.919

9.  Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model.

Authors:  Maitham A Khajah; Kethireddy V Ananthalakshmi; Ivan Edafiogho
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

10.  TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.

Authors:  Nima Etemadi; Michael Chopin; Holly Anderton; Maria C Tanzer; James A Rickard; Waruni Abeysekera; Cathrine Hall; Sukhdeep K Spall; Bing Wang; Yuquan Xiong; Timothy Hla; Stuart M Pitson; Claudine S Bonder; Wendy Wei-Lynn Wong; Matthias Ernst; Gordon K Smyth; David L Vaux; Stephen L Nutt; Ueli Nachbur; John Silke
Journal:  Elife       Date:  2015-12-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.